Budget Amount *help |
¥19,500,000 (Direct Cost: ¥15,000,000、Indirect Cost: ¥4,500,000)
Fiscal Year 2010: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2009: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2008: ¥7,020,000 (Direct Cost: ¥5,400,000、Indirect Cost: ¥1,620,000)
|
Research Abstract |
The purpose of this study is to identify candidate genes of treatment target for schizophrenia. We searched for genes associated with schizophrenia by genome-wide association methods in Japanesepopulations. Among the potentially associated genes identified, we focused on the SMARCA2 gene because psychotogenic drugs lowered Smarca2 expression while antipsychotic drugs increased it in the mouse brain. Furthermore, we found constant expression of Homer1a isoform in Smarca2 knockout mice. The findings of this study indicate that decreased function of SMRACA2 is involved in schizophrenia through glutamatergic synaptic transmission dysfunction and the SMARCA2 gene genotypes might be potential information of personalized medicine in choice of treatment of schizophrenia.
|